Acorda Therapeutics (ACOR) To Showcase Online Multiple Sclerosis Resources At 2014 CMSC/ACTRIMS Meeting
5/27/2014 6:49:49 AM
Acorda Therapeutics, Inc. (Nasdaq:ACOR), a biotechnology company based in New York, will provide demonstrations of its award-winning digital tools for multiple sclerosis (MS) disease management at the 2014 Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), being held May 28–31 in Dallas, Texas. Demonstrations of MoveOverMS.org and the MS self™ multiple sclerosis app will be held in the MoveOverMS.org booth (#406) in the meeting exhibit hall.
Help employers find you! Check out all the jobs and post your resume.
comments powered by